1887

Abstract

Migration from sub-Saharan Africa is contributing to the rising incidence of chronic hepatitis B (CHB) infection and its complications in Australia. African CHB is associated with unique genotypes, such as E and A1, which are associated with reduced vaccine efficacy and early-onset hepatocellular carcinoma, respectively, although the prevalence of these genotypes outside Africa is poorly described. Treatment-naïve children of African origin with CHB were recruited at the Royal Children’s Hospital Melbourne. Population-based sequencing of the complete HBV genome, or the clinically relevant basal core promoter (BCP)/precore (PC) region, was performed, and the HBV genotype/subgenotype assigned by phylogenetic analysis. HBV was characterized in serum from 67 children, median age 12.5 years. HBV genotype E was most frequent (70 %), with genotype D [25 %; subgenotypes D6 (formerly D7)/D3/D2)] and subgenotype A1 (5 %) also being identified. Despite their young age, over 50 % of the children were HBeAg-negative and had seroconverted to anti-HBe, with this being associated with canonical BCP/PC mutations in the majority of cases. The profile of HBV in African children living in Australia was characterized by early HBeAg seroconversion and infection with HBV variants associated with poor clinical outcome, as well as genotypes previously associated with reduced vaccine efficacy or rapid progression to liver cancer. These findings have important ramifications for patient monitoring and treatment guidelines in the Australian paediatric setting.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001086
2018-06-22
2019-09-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/8/1103.html?itemId=/content/journal/jgv/10.1099/jgv.0.001086&mimeType=html&fmt=ahah

References

  1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;388:1081–1088 [CrossRef][PubMed]
    [Google Scholar]
  2. WHO Hepatitis B Fact Sheet World, Health & Organisation (editor) 2017
    [Google Scholar]
  3. MacLachlan JH, Allard N, Towell V, Cowie BC. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health 2013;37:416–422 [CrossRef][PubMed]
    [Google Scholar]
  4. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000;173:403–405[PubMed]
    [Google Scholar]
  5. MacLachlan JH, Cowie BC. Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust 2012;197:492–493 [CrossRef][PubMed]
    [Google Scholar]
  6. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007;37:S9–S19 [CrossRef][PubMed]
    [Google Scholar]
  7. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015;386:1546–1555 [CrossRef][PubMed]
    [Google Scholar]
  8. Office of Home Affairs 2015; Department of Immigration and Citizenship: Immigration Update 2009-10. www.immi.gov.au/media/publications/statistics/
  9. Martin JA, Mak DB. Changing faces: a review of infectious disease screening of refugees by the Migrant Health Unit, Western Australia in 2003 and 2004. Med J Aust 2006;185:607–610[PubMed]
    [Google Scholar]
  10. Rein DB, Lesesne SB, O'Fallon A, Weinbaum CM. Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008. Hepatology 2010;51:431–434 [CrossRef][PubMed]
    [Google Scholar]
  11. Tiong AC, Patel MS, Gardiner J, Ryan R, Linton KS et al. Health issues in newly arrived African refugees attending general practice clinics in Melbourne. Med J Aust 2006;185:602–606[PubMed]
    [Google Scholar]
  12. Ladhani SN, Flood JS, Amirthalingam G, Mieli-Vergani G, Bansal S et al. Epidemiology and clinical features of childhood chronic hepatitis B infection diagnosed in England. Pediatr Infect Dis J 2014;33:130–135 [CrossRef][PubMed]
    [Google Scholar]
  13. Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol 2015;7:289–303 [CrossRef][PubMed]
    [Google Scholar]
  14. Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther 2011;16:1169–1186 [CrossRef][PubMed]
    [Google Scholar]
  15. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83:10538–10547 [CrossRef][PubMed]
    [Google Scholar]
  16. Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology 2014;57:141–150 [CrossRef][PubMed]
    [Google Scholar]
  17. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol 2005;75:513–521 [CrossRef][PubMed]
    [Google Scholar]
  18. Gopalakrishnan D, Keyter M, Shenoy KT, Leena KB, Thayumanavan L et al. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India. World J Gastroenterol 2013;19:9294–9306 [CrossRef][PubMed]
    [Google Scholar]
  19. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004;190:400–408 [CrossRef][PubMed]
    [Google Scholar]
  20. Abushady EA, Gameel MM, Klena JD, Ahmed SF, Abdel-Wahab KS et al. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol 2011;3:147–156 [CrossRef][PubMed]
    [Google Scholar]
  21. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005;25:3–8 [CrossRef][PubMed]
    [Google Scholar]
  22. European Association for the Study of the Liver EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370–398 [CrossRef][PubMed]
    [Google Scholar]
  23. Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol 2011;55:183–191 [CrossRef][PubMed]
    [Google Scholar]
  24. Thurnheer MC, Edwards R, Schulz TR, Yuen L, Littlejohn M et al. Genotypic profiles of hepatitis B in African immigrants and their clinical relevance. J Med Virol 2017;89:1000–1007 [CrossRef]
    [Google Scholar]
  25. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1–98 [CrossRef][PubMed]
    [Google Scholar]
  26. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM. et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261–283 [CrossRef][PubMed]
    [Google Scholar]
  27. Jimenez G, Alex G, Paxton G, Connell TG, Hardikar W. B alert: hepatitis B virus infection in children in Victoria. J Paediatr Child Health 2013;49:E213E216 [CrossRef][PubMed]
    [Google Scholar]
  28. Abdou Chekaraou M, Brichler S, Mansour W, Le Gal F, Garba A et al. A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains. J Gen Virol 2010;91:1609–1620 [CrossRef][PubMed]
    [Google Scholar]
  29. van der Sande MA, Waight PA, Mendy M, Zaman S, Kaye S et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One 2007;2:e753 [CrossRef][PubMed]
    [Google Scholar]
  30. Paxton GA, Rice J, Davie G, Carapetis JR, Skull SA. East African immigrant children in Australia have poor immunisation coverage. J Paediatr Child Health 2011;47:888–892 [CrossRef][PubMed]
    [Google Scholar]
  31. Yousif M, Kramvis A. Genotype D of hepatitis B virus and its subgenotypes: an update. Hepatol Res 2013;43:355–364 [CrossRef][PubMed]
    [Google Scholar]
  32. Chen CY, Crowther C, Kew MC, Kramvis A. A valine to phenylalanine mutation in the precore region of hepatitis B virus causes intracellular retention and impaired secretion of HBe-antigen. Hepatol Res 2008;38:580–592 [CrossRef][PubMed]
    [Google Scholar]
  33. Kramvis A, Kew MC. Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus. Hepatol Res 2007;37:S27–S32 [CrossRef][PubMed]
    [Google Scholar]
  34. Mahgoub S, Candotti D, El Ekiaby M, Allain JP. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol 2011;49:298–306 [CrossRef][PubMed]
    [Google Scholar]
  35. Yousif M, Mudawi H, Bakhiet S, Glebe D, Kramvis A. Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis 2013;13:328 [CrossRef][PubMed]
    [Google Scholar]
  36. Hannachi N, Fredj NB, Bahri O, Thibault V, Ferjani A et al. Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol J 2010;7:302 [CrossRef][PubMed]
    [Google Scholar]
  37. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 2009;90:1622–1628 [CrossRef][PubMed]
    [Google Scholar]
  38. Rodríguez Lay LA, Corredor MB, Villalba MC, Frómeta SS, Wong MS et al. Genetic Diversity of the hepatitis B virus strains in Cuba: absence of West-African genotypes despite the transatlantic slave trade. PLoS One 2015;10:e0125052 [CrossRef][PubMed]
    [Google Scholar]
  39. Karthigesu VD, Allison LM, Ferguson M, Howard CR. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant. J Med Virol 1999;58:346–352 [CrossRef][PubMed]
    [Google Scholar]
  40. Mathet VL, Cuestas ML, Ruiz V, Minassian ML, Rivero C et al. Detection of hepatitis B virus (HBV) genotype E carried-even in the presence of high titers of anti-HBs antibodies-by an Argentinean patient of African descent who had received vaccination against HBV. J Clin Microbiol 2006;44:3435–3439 [CrossRef][PubMed]
    [Google Scholar]
  41. Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M et al. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. Gut 2016
    [Google Scholar]
  42. Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009;137:1593–1608 [CrossRef]
    [Google Scholar]
  43. Boglione L, Cusato J, Cariti G, di Perri G, D'Avolio A. The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon. J Infect 2014;69:81–87 [CrossRef][PubMed]
    [Google Scholar]
  44. Sozzi V, Walsh R, Littlejohn M, Colledge D, Jackson K et al. In vitro studies show that sequence variability contributes to marked variation in hepatitis B virus replication, protein expression, and function observed across genotypes. J Virol 2016;90:10054–10064 [CrossRef][PubMed]
    [Google Scholar]
  45. Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology 2008;47:428–434 [CrossRef][PubMed]
    [Google Scholar]
  46. Günther S, Li BC, Miska S, Krüger DH, Meisel H et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995;69:5437–5444[PubMed]
    [Google Scholar]
  47. Ayres A, Locarnini S, Bartholomeusz A. HBV genotyping and analysis for unique mutations. Methods Mol Med 2004;95:125–150 [CrossRef][PubMed]
    [Google Scholar]
  48. Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A et al. SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B. Antiviral Res 2007;75:64–74 [CrossRef][PubMed]
    [Google Scholar]
  49. Echevarría JM, Avellón A. Hepatitis B virus genetic diversity. J Med Virol 2006;78:S36–S42 [CrossRef][PubMed]
    [Google Scholar]
  50. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL. GenBank. Nucleic Acids Res 2005;33:D34–D38 [CrossRef][PubMed]
    [Google Scholar]
  51. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999;41:95–98
    [Google Scholar]
  52. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725–2729 [CrossRef][PubMed]
    [Google Scholar]
  53. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152–160[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001086
Loading
/content/journal/jgv/10.1099/jgv.0.001086
Loading

Data & Media loading...

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error